Abilify Lawsuit: Background, Risks and Complications

Post on behalf of Thomas J. Ueberschaer PA on Thursday December 27, 2018

Evidence continues to mount against the makers of Abilify. Plaintiffs claim that the drug is responsible for their suffering a range of compulsive behaviors, including, but not limited to, gambling addiction and risky or dangerous sexual engagements, and that the manufacturers, Otsuka Pharmaceutical and Bristol-Myers Squibb, knew about these dangers but failed to warn doctors and patients of the risks.

Click here to learn more about the ongoing investigation into Abilify Lawsuits.

Abilify Background and History

Abilify’s history is littered with settlements and allegations of dangerous risks and complications. To date, Bristol-Myers Squibb and Otsuka Pharmaceutical have paid almost a half a billion dollars following litigation related to Abilify. These suits have spanned allegations related to marketing Abilify for use in situations that were not approved by the FDA (2005), targeting of child psychiatrists and nursing homes (2008), and misrepresentation of studies related to the drug (2016).

In 2016, a warning was issued by the FDA that the connection between Abilify and compulsive behavior was more dangerous than the existing warnings for the drug indicated. The FDA’s statement was that the existing label on aripiprazole, Abilify’s generic name, was insufficient and that it did “…not entirely reflect the nature of the impulse-control risk we identified.”

Attorneys argue that had drug manufacturers adequately warned doctors and patients of the risks associated with the drug, other alternatives could have been prescribed. This would have been especially true in the instances where doctors were able to observe increased compulsive or obsessive behavior after beginning the drug.

This is further supported by the FDA’s finding that in the majority of cases they observed, patients had no prior history of compulsive behaviors before beginning the drug. After starting Abilify (aripiprazole) patients could demonstrate compulsive behaviors within days and after reducing dosage or discontinuing use, the associated obsessive behaviors would stop.

What should you do if you or a loved one experienced obsessive or compulsive behaviors while taking Abilify?

Click here to contact our law firm.

Our law firm has fought for the rights of our clients for over twenty years and we continue to proudly advocate on their behalf. If you or a loved one suffered while taking Abilify, contact our law firm to discuss any potential claim.

Share On: